| Group A | Group B | P | ||||
---|---|---|---|---|---|---|---|
Age, mean (SD), years | 66.3 (7.0) | 66.7 (7.3) | 0.790a | ||||
Sex (female: male) | 18: 11 | 58: 31 | 0.763b | ||||
BCVA, median (IQR), LogMAR | Â | Â | Â | ||||
 Baseline | 0.40 (0.30, 0.50) | 0.40 (0.30, 0.50) | 0.534b | ||||
 3 months | 6 months | 0.20 (0.10, 0.30) | 0.20 (0.00, 0.30) | 0.20 (0.10, 0.40) | 0.10 (0.10, 0.30) | 0.731b | 0.985b |
 P | < 0.001c | < 0.001c | < 0.001c | < 0.001c |  | ||
CMT, mean (SD), µm |  |  |  | ||||
 Baseline | 439.3 (70.0) | 432.2 (87.0) | 0.657a | ||||
 3 months | 6 months | 376.6 (38.2) | 370.7 (34.2) | 360.0 (58.4) | 344.4 (57.3) | 0.156a | < 0.05a |
 P | < 0.001d | < 0.001d | < 0.001d | < 0.001d |  | ||
IRC, n, positive: negative | Â | Â | Â | ||||
 Baseline | 15: 14 | 36: 53 | 0.289b | ||||
 3 months | 6 months | 14: 15 | 12: 17 | 41: 48 | 29: 60 | 0.755b | 0.395b |
 P | 1.000e | 0.508e | 0.383 e | 0.281e |  | ||
EIFL, n, positive: negative | Â | Â | Â | ||||
 Baseline | 22: 7 | 50: 39 | 0.060b | ||||
 3 months | 6 months | 15: 14 | 13: 16 | 32: 57 | 32: 57 | 0.134b | 0.395b |
 P | < 0.05 e | < 0.01e | < 0.001e | < 0.001e |  | ||
ML, n, positive: negative - | 18: 11 | 45: 44 | 0.283b |